NGNE
Neurogene Inc

350
Mkt Cap
$310.88M
Volume
59,618.00
52W High
$37.27
52W Low
$6.88
PE Ratio
-4.52
NGNE Fundamentals
Price
$20.01
Prev Close
$20.07
Open
$20.04
50D MA
$24.71
Beta
1.47
Avg. Volume
261,401.21
EPS (Annual)
-$4.28
P/B
1.11
Rev/Employee
$8,644.86
Loading...
Loading...
News
all
press releases
Neurogene Inc. (NASDAQ:NGNE) Receives Average Recommendation of "Hold" from Brokerages
Shares of Neurogene Inc. (NASDAQ:NGNE - Get Free Report) have been given an average rating of "Hold" by the seven ratings firms that are currently covering the company, MarketBeat.com reports. One...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Recommendation of "Hold" from Brokerages
Neurogene Inc. (NASDAQ:NGNE - Get Free Report) has received an average recommendation of "Hold" from the seven brokerages that are covering the company, MarketBeat.com reports. One analyst has rated...
MarketBeat·2d ago
News Placeholder
Neurogene (NASDAQ:NGNE) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen downgraded Neurogene from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·14d ago
News Placeholder
Neurogene Inc. (NASDAQ:NGNE) Given Average Rating of "Hold" by Brokerages
Shares of Neurogene Inc. (NASDAQ:NGNE - Get Free Report) have been assigned an average recommendation of "Hold" from the seven analysts that are covering the firm, MarketBeat Ratings reports. One...
MarketBeat·26d ago
News Placeholder
FY2025 EPS Estimates for Neurogene Increased by Analyst
Neurogene Inc. (NASDAQ:NGNE - Free Report) - HC Wainwright increased their FY2025 earnings estimates for shares of Neurogene in a report released on Monday, November 17th. HC Wainwright analyst M...
MarketBeat·1mo ago
News Placeholder
Leerink Partnrs Forecasts Stronger Earnings for Neurogene
Neurogene Inc. (NASDAQ:NGNE - Free Report) - Research analysts at Leerink Partnrs upped their FY2026 earnings per share (EPS) estimates for shares of Neurogene in a report released on Wednesday...
MarketBeat·1mo ago
News Placeholder
Neurogene (NASDAQ:NGNE) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised Neurogene from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·1mo ago
News Placeholder
Neurogene (NASDAQ:NGNE) Issues Quarterly Earnings Results
Neurogene (NASDAQ:NGNE - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.99) earnings per share (EPS) for the quarter, beating analysts' consensus...
MarketBeat·1mo ago
News Placeholder
Neurogene (NASDAQ:NGNE) Price Target Raised to $70.00 at HC Wainwright
HC Wainwright lifted their price target on Neurogene from $65.00 to $70.00 and gave the company a "buy" rating in a report on Thursday...
MarketBeat·1mo ago
News Placeholder
Neurogene Reports Third Quarter 2025 Financial Results and Highlights Recent Updates
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced third quarter...
Business Wire·1mo ago
<
1
2
...
>

Latest NGNE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.